Viewpoint Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.54M | Sell |
33,254
-483
| -1% | -$22.4K | 0.76% | 37 |
|
2025
Q1 | $2.06M | Buy |
33,737
+582
| +2% | +$35.5K | 1.11% | 27 |
|
2024
Q4 | $1.88M | Buy |
33,155
+2,579
| +8% | +$146K | 0.98% | 27 |
|
2024
Q3 | $1.56M | Buy |
30,576
+2,205
| +8% | +$112K | 0.87% | 28 |
|
2024
Q2 | $1.18M | Buy |
28,371
+25
| +0.1% | +$1.04K | 0.72% | 32 |
|
2024
Q1 | $1.54M | Sell |
28,346
-2,400
| -8% | -$130K | 0.98% | 29 |
|
2023
Q4 | $1.58M | Sell |
30,746
-846
| -3% | -$43.4K | 1.1% | 26 |
|
2023
Q3 | $1.83M | Buy |
31,592
+543
| +2% | +$31.5K | 1.47% | 22 |
|
2023
Q2 | $1.99M | Buy |
31,049
+183
| +0.6% | +$11.7K | 1.54% | 22 |
|
2023
Q1 | $2.14M | Sell |
30,866
-692
| -2% | -$48K | 1.92% | 15 |
|
2022
Q4 | $2.27M | Sell |
31,558
-2,533
| -7% | -$182K | 2.2% | 14 |
|
2022
Q3 | $2.57M | Sell |
34,091
-2,172
| -6% | -$163K | 2.54% | 9 |
|
2022
Q2 | $2.79M | Buy |
36,263
+188
| +0.5% | +$14.5K | 2.62% | 10 |
|
2022
Q1 | $2.64M | Sell |
36,075
-417
| -1% | -$30.5K | 2.03% | 14 |
|
2021
Q4 | $2.28M | Buy |
+36,492
| New | +$2.28M | 1.65% | 18 |
|